期刊文献+

亲环素A和Krüppel样转录因子2及内皮型一氧化氮合酶在大鼠动脉粥样硬化病变过程中的表达变化 被引量:5

Expression changes of cyclophilin A,Krüppel-like factor 2,and endothelial nitric oxide synthase in the pathological process of atherosclerosis in rats
下载PDF
导出
摘要 目的观察大鼠动脉粥样硬化病变过程中血管壁亲环素A(Cy PA)、Krüppel样转录因子2(KLF2)、内皮型一氧化氮合酶(e NOS)的表达变化。方法将雄性Wistar大鼠32只按数字表法随机分为对照组及动脉粥样硬化8、12、15周组,每组8只。给予动脉粥样硬化组高脂饲料喂养,并给予维生素D3注射液60万IU/kg一次性腹腔注射;给予对照组大鼠基础饲料喂养。在喂养第8、12、15周时处死大鼠,分离腹主动脉,行苏木素-伊红染色,免疫组化法检测动脉壁CyPA、KLF2、eNOS的表达水平。结果随着动脉粥样硬化病变进展,对照组以及动脉粥样硬化8、12、15周组大鼠分别呈现出血管正常结构、内皮细胞破坏、平滑肌细胞增生、粥样斑块形成以及钙化斑块形成等不同的特征。对照组与动脉粥样硬化8、12、15周组间血管壁CyPA、KLF2、eNOS的表达水平差异均有统计学意义(CyPA:0.0037±0.0018、0.0276±0.0090、0.0526±0.0129、0.1080±0.0388;KLF2:0.0932±0.0331、0.0415±0.0076、0.0207±0.0059、0.0014±0.0003;eNOS:0.0358±0.0185、0.0148±0.0080、0.0049±0.0025、0.0037±0.0026;F值分别为36.395、42.108、21.255,均P<0.05),且组间CyPA的表达呈增高趋势,组间两两比较差异有统计学意义(均P<0.05);KLF2表达水平呈进行性下降趋势,组间两两比较差异有统计学意义(均P<0.05);eNOS表达动脉粥样硬化12周组与15周组差异无统计学意义,其他组间差异均有统计学意义(均P<0.05)。结论伴随动脉粥样硬化病变进展,CyPA的表达进行性增高,KLF2、eNOS表达进行性下降。CyPA可能是致动脉粥样硬化病变的途径之一。 Objective To observe the expression changes of cyclophilin A ( CyPA ) , Kr&#252;ppel-like factor 2 (KLF2),and endothelial nitric oxide synthase (eNOS) in the pathological process of atherosclerosis in rats. Methods Thirty-two male Wistar rats were randomly divided into four groups:a control group and atherosclerosis 8,12,and 15 week groups (n=8 in each group). The atherosclerosis groups were fed with high-fat diet,and they were given vitamin D3 600 000 IU for a single intraperitoneal injection,and the rats in the control group were fed with the basal feed. The rats were sacrificed at 8,12,and 15 weeks. Their abdominal aortas were separated and stained with hematoxylin-eosin staining. Immunohistochemical method was used to detect the expression levels of CyPA,KLF2,and eNOS on arterial walls. Results With the progression of atherosclerosis lesion,the rats in the control group,and atherosclerosis 8,12,and 15 week groups showed different characteristics, including normal vessel structure, endothelial cell damage, smooth muscle cell proliferation,formation of atherosclerotic plaque,and formation of calcified plaque. There were significantly differences in the expression levels of CyPA,KLF2,eNOS on vessel walls among the control group,atherosclerosis 8,12,and 15 week groups (CyPA:0. 0037 &#177; 0. 0018,0. 0276 &#177; 0. 0090,0. 0526 &#177; 0. 0129,and 0. 1080 &#177; 0. 0388;KLF2:0. 0932 &#177; 0. 0331,0. 0415 &#177; 0. 0076,0. 0207 &#177; 0. 0059, and 0. 0014 &#177; 0. 0003;eNOS:0. 0358 &#177; 0. 0185,0. 0148 &#177; 0. 0080,0. 0049 &#177; 0. 0025,0. 0037 &#177; 0. 0026;F=36. 395,42. 108,and 21. 255,respectively,all P〈0. 05),and the CyPA expression showed an increasing trend among groups, and there were significant differences between the pairwise comparisons (all P〈0. 05). The expression level of KLF2 showed a progressive declining trend,and there were significant differences between pairwise comparisons (all P 〈0. 05);there was significant difference in eNOS expression between the atherosclerosis 12-week group and the atherosclerosis 15-week group, and there were significant differences among other groups (all P〈0. 05). Conclusion With the progression of atherosclerotic lesions, the expression of CyPA increases progressively, and the expression levels of KLF2 and eNOS decrease progressively. This may be one of the approaches of CyPA caused atherosclerotic lesion.
出处 《中国脑血管病杂志》 CAS CSCD 北大核心 2015年第5期245-249,共5页 Chinese Journal of Cerebrovascular Diseases
基金 湖北省自然科学基金(2013CFB428)
关键词 动脉粥样硬化 亲环素A Krüppel样转录因子类 一氧化氮合酶 Krüppel样转录因子2 Atherosclerosis Cyclophilin A Kruppel-like factors Nitric oxide synthase
  • 相关文献

参考文献14

  • 1Weiner SD, Ahmed HN, Jin Z,et al. Systemic inflammationand brachial artery endothelial function in the Multi-EthnicStudy of Atherosclerosis ( MESA ) [ J ] . Heart, 2014, 100(11):862-866.
  • 2Mao X, Ait-Aissa K, Lagrange J, et al. Hypertension,hypercoagulability and the metabolic syndrome : a cluster ofrisk factors for cardiovascular disease [ J ]. Biomed MaterEng,2012,22( 1-3) :35-48.
  • 3Satoh K,Shimokawa H,Berk BC. Cyclophilin A:promisingnew target in cardiovascular therapy [ J ] . Circ J, 2010,74(11):2249-2256.
  • 4Tian-Tian Z, Jun-Feng Z,Heng G. Functions of cyclophilinA in atherosclerosis [ J ]. Exp Clin Cardiol, 2013,18(2):118.
  • 5Atkins GB,Wang Y,Mahabeleshwar GH,et al. Hemizygousdeficiency of Kriippel-like factor 2 augments experimenta-latherosclerosis[ J]. Circ Res,2008 ,103(7) ;690-693.
  • 6Lingrel JB, Pilcher-Roberts R, Basford JE, et al. Myeloid-specific Kriippel-like factor 2 inactivation increasesmacrophageand neutrophil adhesion and promotesatherosclerosis[ J]. Circ Res ,2012,110( 10) : 1294-1302.
  • 7Parmar KM , Larman HB , Dai G , et al. Integration offlow-dependent endothelial phenotypes by Kriippel-like factor 2[ J]. J Clin Invest,2006,116( 1) :49-58.
  • 8Nigro P,Satoh K,0,Dell MR,et al. Cyclophilin A is aninflammatory mediator that promotes atherosclerosis inapolipoprotein E-deficient mice[ J]. J Exp Med,2011,208(1):53-66.
  • 9Huang Z, Yang P, Radwan Almofti M, et al. Comparativeanalysis of the proteome of left ventricular heart ofarteriosclerosis in rat [ J ]. Life Sci,2004,75 ( 26 ):3103-3115.
  • 10Cullingford TE,Butler MJ, Marshall AK,et al. Differentialregulation of Kriippel-like factor family transcriptionfactorexpression in neonatal rat cardiac myocytes :effects of endothelin-1, oxidative stress and cytokines [ J ].Biochim Biophys Acta,2008,1783(6) : 1229-1236.

二级参考文献11

  • 1Atkins GB, Jain MK. Role of kruppel-like transcription factors in endothelial biology [ J ]. Circ Res, 2007, 100(12) .. 1686-1695.
  • 2Das H, Kumar A, Lin Z, et al. Kriippel-like factor2 (KLF2) regulates proinflammatory activation of monocytes [J]. Proc Natl Acad Sci U S A, 2006, 103 (17): 6653-6658.
  • 3Longa EZ, Weinsteiu PR, Carlson S, et al. Reversible middle cerebral artery occlusion without crainiectomy in rat[ J ]. Stroke, 1989,20( 1 ) :84-91.
  • 4Sieber MW, Claus RA, Witte OW, et al. Attenuated inflammatory responsein aged mice brains following stroke[J]. PLoS One,2011,6(10) :26288.
  • 5Senbanerjee S, Lin Z, Atkins GB, et al. KLF2 is a novel transcriptional regulator of endothelial proinflammatory activation[ J]. J Exp Med,2004,199(10) : 1305-1315.
  • 6Shi H, Sheng B, Zhang F, et al. Krtippel-like factor 2 protects against ischemic stroke by regulating endothelial blood brain barrier function [ J ]. Am J Physiol Heart Circ Physiol,2013,304(6) :796-805.
  • 7Fledderus JO,Van Thienen JV, Boon RA, et al. Prolonged shear stress and KL[2 suppress constitutive proinflammatory transcription through inhibition of ATF2 [ J 1- Blood, 2007, 109(10) :4249-4257.
  • 8Mahabeleshwar GH, Kawanami D, Sharma N, et al. The myeloid transcription factor KLF2 regulates the host response to polymicrobial infection and endotoxic shock[ J]. Immunity,2011,34(5) :715-728.
  • 9Allen KL, Hamik A, Jain MK, et al. Endothelial cell activation by antiphospholipid antibodies is modulated by Krtippel-like transcription factors [ J 1- Blood, 2011, 117 (23) :6383-6391.
  • 10Zahlten J, Steinicke R, Opitz B, et al. TLR2 and nucleotide binding oligomerization domain 2-dependent Krtippel-like factor 2 expression down regulates NF-kappa B-related gene expression[ J]. J Immuno1,2010,185 ( 1 ) :597-604.

共引文献1

同被引文献65

  • 1吕新华,何勇,廖昆,熊清萍.不稳定型心绞痛患者肿瘤坏死因子-α和白细胞介素-6活性水平观察[J].临床急诊杂志,2005,6(6):11-12. 被引量:2
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33058
  • 3Chen YX, Zhang M, Cai Y, et al. The Sirtl activator SRT1720 attenuates angiotensin H-induced alherosclerosis in apoE (-/-) mice throughinhibiting vascular inflammatory response[ J]. Biochem Biophys Res Commun, 2015, 465 (4) : 732-738.
  • 4Peretti CS, Peretti CR, Kozora E, et al. Cognitive impairment in systemic lupus erythematosus women with elevated autoantibodies and normal single photon emission computerized tomography[ J]. Psychother Psychosom, 2012,81(5) :276-285.
  • 5Adams HP Jr, Bendixen BH, Kappelle LJ ,et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment[ J]. Stroke, 1993,24( 1 ) :35-41.
  • 6North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis[ J]. N Engl J Med, 1991,325 (7) :445-453.
  • 7Ding D. Management of intracranial atherosclerotie disease: current roles of medical therapy versus stent- assisted revascularization [ J ]. Neurol Sci, 2015,36 ( 8 ) : 1531-1532.
  • 8Bonaccorsi I, De Pasquale C, Campana S, et al. Natural killer cells in the innate immunity network of athero- sclerosis[ J]. Immunol Lett,2015,168( 1 ) :51-57.
  • 9Li Q,Wang Y,Yu F, et al. Peripheral Thl7/Treg imbalance in patients with atherosclerotic cerebral infarction[ J]. Int J Clin Exp Pathol, 2013,6(6): 1015-1027.
  • 10. Arvanitakis Z, Brey RL, Rand JH, et al. Relation of antiphospholipid antibodies to postmortem brain infarcts in older people[ J]. Circulation,2015,131 (2) : 182-189.

引证文献5

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部